The discussions reflect a balanced view of the article, with posts referencing details such as the percentage of individuals seeking treatment after challenging experiences and emphasizing the importance of harm reduction, using words like 'benefited', 'risks', and 'important details'. The tone combines scientific acknowledgment with practical concerns, demonstrating a thoughtful engagement with the research.
AgreementModerate agreement
Most discussions acknowledge the findings of the study, recognizing both the risks and benefits of psilocybin use, which indicates general support or acceptance of the research outcomes.
InterestHigh interest
The discussion demonstrates a high level of curiosity, with many users referencing specific studies, risk factors, and implications for public understanding, showing active engagement.
EngagementModerate engagement
Participants delve into detailed aspects like dosage equivalence, risk factors, and harm reduction strategies, reflecting thoughtful and moderate engagement rather than superficial commentary.
ImpactModerate impact
While the discussions highlight important considerations and advocate for increased awareness, they mostly serve to inform or shape attitudes rather than directly influence policy or widespread change.
Abstract in brief
This survey of 1993 individuals who had a challenging psilocybin mushroom experience found that while some participants faced significant psychological and physical risks, most benefited overall and reported lasting positive effects.
Factors such as higher doses, longer durations, and lack of social support increased the likelihood of risky behaviors and psychological distress, with some cases leading to medical treatment, aggressive behavior, or enduring mental health issues.
Despite the risks, the study suggests that, in controlled laboratory settings with properly screened and supported participants, psilocybin's adverse effects are rare, and many individuals experience meaningful and lasting psychological benefits.]
Carbonaro, T. M. et al. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268–1278.
Jun 17, 2021 · 41 likes · 30,372 followersView post →
DY
David B. Yaden
@ExistWell · X
Also, there are real risks to psychedelic use. Many of these risks are minimized in clinical settings, but even in clinical settings there are real risks (as there are with virtually every effective treatment).
https://t.co/3PkMnmKDsL
Aug 31, 2022 · 26 likes · 3 shares · 7,188 followersView post →
DS
Dr. Fabian Pitter STEINMETZ
@docsteinmetz · X
So muss #HarmReduction & #Drogen-#Aufklärung sein!
#Psilos #Psilocybe #Psilocybin #BlauenderKahlkopf #PsilocybeCyanescens #Psychedelika #Pilze #Medizin #Gesundheit #Recht #SaferUse
Nov 2, 2020 · 22 likes · 4 shares · 12,857 followersView post →
DY
David B. Yaden
@ExistWell · X
@jamesbclose @JulesEvans11 @AlexLiviaJones @Josh__Hardman @Neuro_Skeptic Agreed! Some papers cited:
Bursting the Psychedelic Hype Bubble
https://t.co/LnkkUMwXrj
Bayesian reanalysis of psilocybin trial
(for best effect size estimates)
https://t.co/j4hmS7K9sL
(for challenging exp/risks)
https://t.co/3PkMnmtAqL
(for harms)
https://t.co/cwhY2kywmM
Jun 29, 2023 · 7 likes · 7,188 followersView post →
KR
Katja R.
@Rosenblumen0 · X
Verwechseln Sie beim Pilze sammeln sich bitte nicht mit diesem Pilz!...was für ne Wortwahl
Oct 31, 2023 · 6 likes · 1 share · 2,127 followersView post →
DD
David Puder M.D.
@DavidPuder · X
From this article: To look at the long term positive and negative consequences of psilocybin use, in particular, we read this Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences (Carbonaro et al.,
Blauende Kahlköpfe are small magic mushrooms containing psilocybin, found in unexpected places around your home. We discuss their identification, location, active ingredients, and the potential effects and risks…
A few weeks ago, I tested the psychedelic mushrooms, a lesser-known drug in the psychoactive family. Psilocybin, the active component, may have benefits for treating depression, addiction, and anxiety, and could improve…
This video explores the five biggest myths about magic mushrooms, particularly in relation to their medicinal potential. Highlighted within are findings on psilocybin therapy's promise for treating major depressive…
@BuenoForMiami 1.
Carbonaro TM, Bradstreet MP, Barrett FS, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology. 2016;30(12):1268-1278. doi:10.1177/0269881116662634
Verwechseln Sie beim Pilze sammeln sich bitte nicht mit diesem Pilz!...was für ne Wortwahl
Oct 31, 2023 · 6 likes · 1 share · 2,127 followersView post →
KR
Katja R.
@Rosenblumen0 · X
Wenn Sie #Speisepilze sammeln, verwechseln Sie bitte sich nicht mit diesem Pilz! Absolute Kanalempfehlung, da dieser Kanal sich allgemein mehr mit Speisepilzen und deren giftige Doppelgänger. https://t.co/IDVpV7arYT
#BlauenderKahlkopf #Psilocybine #Prävention #Pilz #Pilze
Oct 6, 2023 · 5 likes · 2,127 followersView post →
From this article: To look at the long term positive and negative consequences of psilocybin use, in particular, we read this Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences (Carbonaro et al.,
@jamesbclose @JulesEvans11 @AlexLiviaJones @Josh__Hardman @Neuro_Skeptic Agreed! Some papers cited:
Bursting the Psychedelic Hype Bubble
https://t.co/LnkkUMwXrj
Bayesian reanalysis of psilocybin trial
(for best effect size estimates)
https://t.co/j4hmS7K9sL
(for challenging exp/risks)
https://t.co/3PkMnmtAqL
(for harms)
https://t.co/cwhY2kywmM
Jun 29, 2023 · 7 likes · 7,188 followersView post →
BS
Balázs Szigeti
@psybalazs · X
The number I cite above is based on two papers. The first one https://t.co/B1mItWRyUE says: "we estimate that 4 g of typically available dried mushrooms (P. cubensis) delivers the approximate psychoactive equivalent to 25 mg of psilocybin"
Mar 29, 2023 · 4 likes · 3,286 followersView post →
DY
David B. Yaden
@ExistWell · X
It should be obvious that psychedelic experiences are often challenging, sometimes very difficult, and can be extremely negative in some cases.
A nice frequently referenced review here:
https://t.co/3PkMnmKDsL
Dec 5, 2022 · 3 likes · 7,188 followersView post →
S
ShroomWire
@ShroomWire · X
@Waracken @Serotonin2arec @drrickbarnett Here is a paper on outcomes from bad trips, if interested: https://t.co/kCqo9GUSKC
Most said they benefited, but 8% said a bad trip on shrooms negatively affected them. I care about that 8%. Many important details about risk factors for bad outcomes
@JasterAlaina https://t.co/q54srR7IRS
With psilocybin, "...degree of difficulty was positively associated, & duration was negatively associated, w/ enduring increases in well-being."
On the other hand, "7.6% sought treatment for enduring psych symptoms... 3 cases with attempted suicide."
@britcoal @thefriffin @JYFboy @xtinacomputes With the number of people who recreationally take drugs, a small influence can have a big impact on meaningful numbers of people.
https://t.co/WBh7SNjm9N https://t.co/bKWrxK9col
RT @ExistWell: Also, there are real risks to psychedelic use. Many of these risks are minimized in clinical settings, but even in clinical…
Aug 31, 2022 · 3 shares · 386 followersView post →
JG
Jaqueline Nava-Gómez ♪
@Jaquelinesdi25 · X
RT @ExistWell: Also, there are real risks to psychedelic use. Many of these risks are minimized in clinical settings, but even in clinical…
Aug 31, 2022 · 3 shares · 886 followersView post →
Y
YogaKneez
@YogaKneez · X
RT @ExistWell: Also, there are real risks to psychedelic use. Many of these risks are minimized in clinical settings, but even in clinical…
Aug 31, 2022 · 3 shares · 2,182 followersView post →
DY
David B. Yaden
@ExistWell · X
Also, there are real risks to psychedelic use. Many of these risks are minimized in clinical settings, but even in clinical settings there are real risks (as there are with virtually every effective treatment).
https://t.co/3PkMnmKDsL
Aug 31, 2022 · 26 likes · 3 shares · 7,188 followersView post →
#icanhazpdf Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Mar 16, 2022 · 1 like · 1 share · 20 followersView post →
DY
David B. Yaden
@ExistWell · X
@shayla__love Agree that way more can be done, especially in the public arena and press. Attention is paid to the possibility of adverse effects in consent documents and are measured (eg
https://t.co/p6FpQDGF1o), but agree this is a very important issue to keep working on at multiple levels!
Nice article to review from 2016 in Journal of Psychopharmacology.
@FredBarrettPhD https://t.co/CKswAaYQZT
Jul 7, 2021 · 1 like · 17,578 followersView post →
ME
Mateus, especialista em
@mateusdosfungos · X
Carbonaro, T. M. et al. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268–1278.
Jun 17, 2021 · 41 likes · 30,372 followersView post →
HD
Haley Maria Dourron
@HDourron · X
@pt___ @BasicMorality @RCarhartHarris Yes, research tends to suggest that even with extremely challenging experiences there is typically enduring benefit.
Survey Study: https://t.co/llSNSQaEVe
Case Studies: https://t.co/W2vxTlz3U1
Nov 12, 2020 · 2 likes · 1,941 followersView post →
A
Acme
@69Acme69 · X
RT @DocTailleur: So muss #HarmReduction & #Drogen-#Aufklärung sein!
#Psilos #Psilocybe #Psilocybin #BlauenderKahlkopf #PsilocybeCyanescens…
So muss #HarmReduction & #Drogen-#Aufklärung sein!
#Psilos #Psilocybe #Psilocybin #BlauenderKahlkopf #PsilocybeCyanescens #Psychedelika #Pilze #Medizin #Gesundheit #Recht #SaferUse
Nov 2, 2020 · 22 likes · 4 shares · 12,857 followersView post →
SP
Stephen Pimentel
@StephenPiment · X
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences https://t.co/wjnhY43EIw
doi: 10.1177/0269881116662634. Frontiers in Psychiatry | www.frontiersin.org 12 January 2020 | Volume 10 | Article 943. Fuentes et al. Therapeutic Use of LSD.
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution ...
News
psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268-1278. doi:10.1177/0269881116662634
BMJ 2023 078084.full | PDF | Systematic Review | Major Depressive ...
News
Protected by copyright. consequences. J Psychopharmacol 2016;30:1268-78. pbj.0000000000000128 doi:10.1177/0269881116662634 33 Li NX, Hu YR, Chen WN, Zhang B ...
New Strange Odd and Weird Perceptions - Davis - Timmy 2020 ...
News
https://doi.org/10.1177/0269881116662634. 98. Lacunae, Issue 21, December 2020. Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge,. M., Feilding, A ...
How To Set Up A Psychedelic Study: Unique Considerations For ...
News
Journal of Psychopharmacology, 30(12), 1268–1278. https://doi.org/10.1177/0269881116662634. Carbonaro, T. M., Johnson, M. W., Hurwitz, E., & Griffiths, R. R. ...
org/10.1177/0269881116662634. tional Academy of Sciences of the United States of America, Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M., Kaelen ...
ME
DY
DD
M
BS
S
CI
不
C
JG
Y
S
RM
DP
HD
SP